Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2025 08:00 ET | Source: BioCardia, Inc.

BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System

SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
July 08, 2024 07:00 ET | Source: BioCardia, Inc.

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction

CellProthera, and BioCardia [Nasdaq: BCDA], today announce success from a collaborative Phase II trial of ProtheraCytes for the treatment of AMI.
March 27, 2024 16:00 ET | Source: BioCardia, Inc.

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia®, Inc. today reported financial results for the year ended December 31, 2023
January 03, 2024 07:00 ET | Source: BioCardia, Inc.

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders

SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
June 08, 2023 07:00 ET | Source: BioCardia, Inc.

BioCardia Announces Helix™ Biotherapeutic Delivery Patent Issuance in Japan

SUNNYVALE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
October 12, 2021 08:00 ET | Source: BioCardia, Inc.

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies

SAN CARLOS, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and...
December 30, 2020 08:30 ET | Source: BioCardia, Inc.

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

SAN CARLOS, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...